 | • レポートコード：20QY06-00432 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、mRNAワクチンおよび治療薬のグローバル市場について種類別（癌治療MRNAワクチン標準化、癌治療MRNAワクチン個別化、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別（感染症、癌、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・mRNAワクチンおよび治療薬市場の概要 ・世界の主要地域別mRNAワクチンおよび治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のmRNAワクチンおよび治療薬市場規模2015-2026：種類別（癌治療MRNAワクチン標準化、癌治療MRNAワクチン個別化、感染症治療MRNAワクチン、感染予防MRNAワクチン） ・世界のmRNAワクチンおよび治療薬市場規模2015-2026：用途別（感染症、癌、その他） ・mRNAワクチンおよび治療薬の北米市場規模2015-2020 ・mRNAワクチンおよび治療薬のヨーロッパ市場規模2015-2020 ・mRNAワクチンおよび治療薬の中国市場規模2015-2020 ・mRNAワクチンおよび治療薬の日本市場規模2015-2020 ・mRNAワクチンおよび治療薬の東南アジア市場規模2015-2020 ・mRNAワクチンおよび治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Moderna Therapeutics、CureVac、Translate Bio、BioNTech、Sangamo Therapeutics、Argos Therapeutics、In-Cell-Art、eTheRNA、Ethris、Tiba Biotechnology） ・mRNAワクチンおよび治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・mRNAワクチンおよび治療薬の市場動向・機会・課題 ・調査の結論 |
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
mRNA Cancer Vaccines and Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Cancer Vaccines and Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications. The research of mRNA Cancer Vaccines and Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 45.7% in 2018.
Market Analysis and Insights: Global mRNA Vaccines & Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the mRNA Vaccines & Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the mRNA Vaccines & Therapeutics industry.
Based on our recent survey, we have several different scenarios about the mRNA Vaccines & Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1176.3 million in 2019. The market size of mRNA Vaccines & Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global mRNA Vaccines & Therapeutics Scope and Market Size
The global mRNA Vaccines & Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the mRNA Vaccines & Therapeutics market is segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
Segment by Application, the mRNA Vaccines & Therapeutics market is segmented into
Infectious Disease
Cancer
Other
The mRNA Vaccines & Therapeutics market is analysed and market size information is provided by regions (countries). Segment by Application, the mRNA Vaccines & Therapeutics market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and mRNA Vaccines & Therapeutics Market Share Analysis
mRNA Vaccines & Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in mRNA Vaccines & Therapeutics business, the date to enter into the mRNA Vaccines & Therapeutics market, mRNA Vaccines & Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
1 mRNA Vaccines & Therapeutics Market Overview
1.1 mRNA Vaccines & Therapeutics Product Scope
1.2 mRNA Vaccines & Therapeutics Segment by Type
1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020-2026)
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 mRNA Vaccines & Therapeutics Segment by Application
1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2020-2026)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2015-2026)
1.4.1 Global mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2026)
1.4.2 Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2026)
1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): mRNA Vaccines & Therapeutics Industry Impact
1.5.1 How the Covid-19 is Affecting the mRNA Vaccines & Therapeutics Industry
1.5.1.1 mRNA Vaccines & Therapeutics Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and mRNA Vaccines & Therapeutics Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for mRNA Vaccines & Therapeutics Players to Combat Covid-19 Impact
2 mRNA Vaccines & Therapeutics Estimate and Forecast by Region
2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2015-2020)
2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2015-2020)
2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
2.4.2 Europe mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
2.4.3 China mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
2.4.4 Japan mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
2.4.5 Southeast Asia mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
2.4.6 India mRNA Vaccines & Therapeutics Estimates and Projections (2015-2026)
3 Global mRNA Vaccines & Therapeutics Competition Landscape by Players
3.1 Global Top mRNA Vaccines & Therapeutics Players by Sales (2015-2020)
3.2 Global Top mRNA Vaccines & Therapeutics Players by Revenue (2015-2020)
3.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)
3.4 Global mRNA Vaccines & Therapeutics Average Price by Company (2015-2020)
3.5 Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key mRNA Vaccines & Therapeutics Players (Opinion Leaders)
4 Global mRNA Vaccines & Therapeutics Market Size by Type
4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2015-2020)
4.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2015-2020)
4.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2014-2020)
4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2021-2026)
5 Global mRNA Vaccines & Therapeutics Market Size by Application
5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2015-2020)
5.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
5.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)
5.1.3 Global mRNA Vaccines & Therapeutics Price by Application (2015-2020)
5.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Application (2021-2026)
3 North America mRNA Vaccines & Therapeutics Market Facts & Figures
3.2 North America mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
3.3 North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
3.4 North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
4 Europe mRNA Vaccines & Therapeutics Market Facts & Figures
4.2 Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
4.3 Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
4.4 Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
5 China mRNA Vaccines & Therapeutics Market Facts & Figures
5.2 China mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
5.3 China mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
5.4 China mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
6 Japan mRNA Vaccines & Therapeutics Market Facts & Figures
6.2 Japan mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
6.3 Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
6.4 Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
7 Southeast Asia mRNA Vaccines & Therapeutics Market Facts & Figures
7.2 Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
7.3 Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
7.4 Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
8 India mRNA Vaccines & Therapeutics Market Facts & Figures
8.2 India mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
8.3 India mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
8.4 India mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in mRNA Vaccines & Therapeutics Business
12.1 Moderna Therapeutics
12.1.1 Moderna Therapeutics mRNA Vaccines & Therapeutics Corporation Information
12.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Products Offered
12.1.5 Moderna Therapeutics Recent Development
12.2 CureVac
12.2.1 CureVac mRNA Vaccines & Therapeutics Corporation Information
12.2.2 CureVac mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CureVac mRNA Vaccines & Therapeutics Products Offered
12.2.5 CureVac Recent Development
12.3 Translate Bio
12.3.1 Translate Bio mRNA Vaccines & Therapeutics Corporation Information
12.3.2 Translate Bio mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Translate Bio mRNA Vaccines & Therapeutics Products Offered
12.3.5 Translate Bio Recent Development
12.4 BioNTech
12.4.1 BioNTech mRNA Vaccines & Therapeutics Corporation Information
12.4.2 BioNTech mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.4.4 BioNTech mRNA Vaccines & Therapeutics Products Offered
12.4.5 BioNTech Recent Development
12.5 Sangamo Therapeutics
12.5.1 Sangamo Therapeutics mRNA Vaccines & Therapeutics Corporation Information
12.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Products Offered
12.5.5 Sangamo Therapeutics Recent Development
12.6 Argos Therapeutics
12.6.1 Argos Therapeutics mRNA Vaccines & Therapeutics Corporation Information
12.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Products Offered
12.6.5 Argos Therapeutics Recent Development
12.7 In-Cell-Art
12.7.1 In-Cell-Art mRNA Vaccines & Therapeutics Corporation Information
12.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Products Offered
12.7.5 In-Cell-Art Recent Development
12.8 eTheRNA
12.8.1 eTheRNA mRNA Vaccines & Therapeutics Corporation Information
12.8.2 eTheRNA mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.8.4 eTheRNA mRNA Vaccines & Therapeutics Products Offered
12.8.5 eTheRNA Recent Development
12.9 Ethris
12.9.1 Ethris mRNA Vaccines & Therapeutics Corporation Information
12.9.2 Ethris mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ethris mRNA Vaccines & Therapeutics Products Offered
12.9.5 Ethris Recent Development
12.10 Tiba Biotechnology
12.10.1 Tiba Biotechnology mRNA Vaccines & Therapeutics Corporation Information
12.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Business Overview and Total Revenue
12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Products Offered
12.10.5 Tiba Biotechnology Recent Development
13 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
13.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
13.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 mRNA Vaccines & Therapeutics Distributors List
14.3 mRNA Vaccines & Therapeutics Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global mRNA Vaccines & Therapeutics Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four mRNA Vaccines & Therapeutics Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for mRNA Vaccines & Therapeutics Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for mRNA Vaccines & Therapeutics Players to Combat Covid-19 Impact
Table 8. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global mRNA Vaccines & Therapeutics Sales (K Units) by Region (2015-2020)
Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2015-2020)
Table 11. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2015-2020)
Table 13. Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2021-2026)
Table 15. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2021-2026)
Table 17. Global mRNA Vaccines & Therapeutics (K Units) of Key Companies (2015-2020)
Table 18. Global mRNA Vaccines & Therapeutics Sales Share by Company (2015-2020)
Table 19. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) by Company (2015-2020)
Table 20. Global mRNA Vaccines & Therapeutics Revenue Share by Company (2015-2020)
Table 21. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccines & Therapeutics as of 2019)
Table 22. Global mRNA Vaccines & Therapeutics Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers mRNA Vaccines & Therapeutics Manufacturing Sites and Area Served
Table 24. Manufacturers mRNA Vaccines & Therapeutics Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key mRNA Vaccines & Therapeutics Players
Table 27. Global mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 28. Global mRNA Vaccines & Therapeutics Sales Share by Type (2015-2020)
Table 29. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2015-2020)
Table 31. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)
Table 32. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)
Table 34. Global mRNA Vaccines & Therapeutics Price (K Units) by Type (2021-2026)
Table 35. Global mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 36. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)
Table 37. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global mRNA Vaccines & Therapeutics Price (K Units) by Application (2015-2020)
Table 39. Global mRNA Vaccines & Therapeutics Sales (K Units) by Application (2021-2026)
Table 40. Global mRNA Vaccines & Therapeutics Sales Share by Application (2021-2026)
Table 41. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2021-2026)
Table 43. Global mRNA Vaccines & Therapeutics Price (K Units) by Application (2021-2026)
Table 44. United States mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 45. United States mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 46. United States mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 47. United States mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 48. United States mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 49. United States mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 50. Europe mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 52. Europe mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 53. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 54. Europe mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 55. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 56. China mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 57. China mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 58. China mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 59. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 60. China mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 61. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 62. Japan mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 63. Japan mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 64. Japan mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 65. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 66. Japan mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 67. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 74. India mRNA Vaccines & Therapeutics Sales (K Units) by Company (2015-2020)
Table 75. India mRNA Vaccines & Therapeutics Sales Market Share by Company (2015-2020)
Table 76. India mRNA Vaccines & Therapeutics Sales (K Units) by Type (2015-2020)
Table 77. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)
Table 78. India mRNA Vaccines & Therapeutics Sales (K Units) by Application (2015-2020)
Table 79. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
Table 80. Moderna Therapeutics Corporation Information
Table 81. Moderna Therapeutics Description and Business Overview
Table 82. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
Table 84. Moderna Therapeutics Recent Development
Table 85. CureVac Corporation Information
Table 86. CureVac Description and Business Overview
Table 87. CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. CureVac mRNA Vaccines & Therapeutics Product
Table 89. CureVac Recent Development
Table 90. Translate Bio Corporation Information
Table 91. Translate Bio Description and Business Overview
Table 92. Translate Bio mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Translate Bio mRNA Vaccines & Therapeutics Product
Table 94. Translate Bio Recent Development
Table 95. BioNTech Corporation Information
Table 96. BioNTech Description and Business Overview
Table 97. BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. BioNTech mRNA Vaccines & Therapeutics Product
Table 99. BioNTech Recent Development
Table 100. Sangamo Therapeutics Corporation Information
Table 101. Sangamo Therapeutics Description and Business Overview
Table 102. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
Table 104. Sangamo Therapeutics Recent Development
Table 105. Argos Therapeutics Corporation Information
Table 106. Argos Therapeutics Description and Business Overview
Table 107. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Argos Therapeutics mRNA Vaccines & Therapeutics Product
Table 109. Argos Therapeutics Recent Development
Table 110. In-Cell-Art Corporation Information
Table 111. In-Cell-Art Description and Business Overview
Table 112. In-Cell-Art mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. In-Cell-Art mRNA Vaccines & Therapeutics Product
Table 114. In-Cell-Art Recent Development
Table 115. eTheRNA Corporation Information
Table 116. eTheRNA mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. eTheRNA Description and Business Overview
Table 118. eTheRNA mRNA Vaccines & Therapeutics Product
Table 119. eTheRNA Recent Development
Table 120. Ethris Corporation Information
Table 121. Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Ethris Description and Business Overview
Table 123. Ethris mRNA Vaccines & Therapeutics Product
Table 124. Ethris Recent Development
Table . Tiba Biotechnology Corporation Information
Table . Tiba Biotechnology Description and Business Overview
Table . Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Tiba Biotechnology mRNA Vaccines & Therapeutics Product
Table . Tiba Biotechnology Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. mRNA Vaccines & Therapeutics Distributors List
Table 133. mRNA Vaccines & Therapeutics Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Product Picture
Figure 2. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 2020 & 2026
Figure 6. Infectious Disease Examples
Figure 7. Cancer Examples
Figure 8. Other Examples
Figure 9. Global mRNA Vaccines & Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States mRNA Vaccines & Therapeutics Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe mRNA Vaccines & Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China mRNA Vaccines & Therapeutics Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan mRNA Vaccines & Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia mRNA Vaccines & Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India mRNA Vaccines & Therapeutics Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India mRNA Vaccines & Therapeutics Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest mRNA Vaccines & Therapeutics Players Market Share by Revenue in mRNA Vaccines & Therapeutics 2015 & 2019
Figure 27. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)
Figure 29. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2015-2020)
Figure 31. Global mRNA Vaccines & Therapeutics Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 33. United States mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 34. Europe mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019
Figure 35. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 36. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 37. China mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019
Figure 38. China mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 39. China mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 40. Japan mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019
Figure 41. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 42. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 43. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019
Figure 44. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 45. Southeast Asia mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 46. India mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019
Figure 47. India mRNA Vaccines & Therapeutics Sales Market Share by Type in 2019
Figure 48. India mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 49. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure 61. Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure 62. mRNA Vaccines & Therapeutics Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
mRNAワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The mRNA Vaccine market report provi…- H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- マラリアワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Malaria Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.4% in the forecast period of 2020 to 2025 and will expected to reach USD 23 million by 2025, from USD 14 million in 2019. The Malaria Vaccines market re…
- 結核ワクチン治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…